- Home
- MTRX vs PSNL Comparison
MTRX vs PSNL Comparison
Compare MTRX & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTRX
- PSNL
- Stock Information
- Founded
- MTRX 1984
- PSNL 2011
- Country
- MTRX United States
- PSNL United States
- Employees
- MTRX N/A
- PSNL N/A
- Industry
- MTRX Engineering & Construction
- PSNL Medical Specialities
- Sector
- MTRX Consumer Discretionary
- PSNL Health Care
- Exchange
- MTRX Nasdaq
- PSNL Nasdaq
- Market Cap
- MTRX 405.6M
- PSNL 484.0M
- IPO Year
- MTRX 1990
- PSNL 2019
- Fundamental
- Price
- MTRX $14.58
- PSNL $5.24
- Analyst Decision
- MTRX Strong Buy
- PSNL Strong Buy
- Analyst Count
- MTRX 1
- PSNL 4
- Target Price
- MTRX $20.00
- PSNL $8.13
- AVG Volume (30 Days)
- MTRX 136.5K
- PSNL 900.5K
- Earning Date
- MTRX 11-05-2025
- PSNL 11-05-2025
- Dividend Yield
- MTRX N/A
- PSNL N/A
- EPS Growth
- MTRX N/A
- PSNL N/A
- EPS
- MTRX N/A
- PSNL N/A
- Revenue
- MTRX $742,408,000.00
- PSNL $80,317,000.00
- Revenue This Year
- MTRX $9.98
- PSNL N/A
- Revenue Next Year
- MTRX $20.42
- PSNL $29.83
- P/E Ratio
- MTRX N/A
- PSNL N/A
- Revenue Growth
- MTRX N/A
- PSNL 0.36
- 52 Week Low
- MTRX $9.14
- PSNL $2.83
- 52 Week High
- MTRX $16.11
- PSNL $7.79
- Technical
- Relative Strength Index (RSI)
- MTRX 47.35
- PSNL 54.55
- Support Level
- MTRX $14.17
- PSNL $4.73
- Resistance Level
- MTRX $15.89
- PSNL $4.97
- Average True Range (ATR)
- MTRX 0.49
- PSNL 0.26
- MACD
- MTRX -0.10
- PSNL 0.10
- Stochastic Oscillator
- MTRX 23.84
- PSNL 96.39
About MTRX Matrix Service Company
Matrix Service Co is an engineering and construction provider for large industrial projects, primarily in the oil and gas, power, petrochemical, industrial, mining, and minerals markets. It offers engineering, fabrication, construction, and maintenance services, operating across three segments namely Utility and Power Infrastructure; Process and Industrial Facilities; and Storage and Terminal Solutions.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.